Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 001-39295 (Commission File Number) SelectQuote, Inc. (Exact name of registrant as specified in its charter) Delaware 94-3339273 (State or other j ...

Financial Data and Key Metrics Changes - SelectQuote reported consolidated revenue of $405 million, a 27% year-over-year increase, and adjusted EBITDA of $67 million compared to $64 million a year ago [13][28] - Adjusted EBITDA margin declined due to a higher mix of healthcare services revenue, with healthcare services revenue more than doubling year-over-year to $112 million [13][28] - The company expects to approach breakeven free cash flow for fiscal 2024, with cash flow generation anticipated to expand as healthcare services scale [7][12] Business Line Data and Key Metrics Changes - In the Senior segment, revenue grew to $248 million, an 11% increase year-over-year, driven primarily by Medicare Advantage policy growth [36] - The lifetime value (LTV) of policies increased by 7% to $934 per policy, reflecting stable policyholder persistency [9][36] - The Healthcare Services segment surpassed original member growth expectations, reaching nearly 63,000 members, with a sequential growth of 19% compared to the previous quarter [16][29] Market Data and Key Metrics Changes - The company noted a more rational competitive landscape in the industry compared to previous years, with stable agent efficiency despite increased marketing costs due to new CMS marketing rules [9][15] - The average prescription shipped per member grew by 76% year-over-year, indicating significant scale in the distribution business [38] Company Strategy and Development Direction - SelectQuote aims to generate stable and attractive EBITDA margins while focusing on returns to invested capital and growing cash flow [6] - The company is leveraging its existing marketing spend to create new revenue streams, particularly in healthcare services, which is expected to drive future growth [49][74] - The strategic focus includes enhancing automation and improving system architecture to reduce costs while continuing to grow [68] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to maintain persistency and stability in policyholder retention, despite increased shopping behavior in the market [23][65] - The company is optimistic about the future, citing strong performance in both the Senior and Healthcare Services divisions, and has increased revenue and adjusted EBITDA outlooks for fiscal 2024 [27][40] Other Important Information - SelectQuote is actively working on restructuring its balance sheet to improve its earnings profile and operating flexibility, with a focus on securitization as a potential solution [20][56] - The company highlighted that it is on track to produce approximately $100 million of unlevered operating cash flow in fiscal 2024 [20] Q&A Session Summary Question: What are the prospects for continued synergies between the pharmacy business and the senior segment? - Management highlighted strong growth in SelectRx, indicating significant synergy with the Medicare Advantage customer base and potential for further adoption [63][64] Question: How does the company view its debt levels as it progresses towards free cash flow generation? - Management acknowledged the meaningful debt balance and emphasized that addressing it is a priority, with ongoing negotiations for a long-term solution [56][70] Question: Can you comment on the lifetime value outlook and the impact of carrier mix? - Management expressed confidence in maintaining persistency and noted that the stabilization observed is a strong foundation for future growth [22][45]

*See "Non-GAAP Financial Measures" above on slide 2. $90 $MM | We shop. You save. MA LTV | We shop. You save. 8 LTM 9/30/22 LTM 9/30/23 9 60,000 $MM | We shop. You save. l | | l $37 $38 $7 $9 Life Auto & Home 1Q23 1Q24 $5 $5 $2 $3 Life Auto & Home 1Q23 1Q24 11 12 | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |------------------------------------------------------------------------------|-------|--------|-------|----------------------|-------|------------|-------------|-------|--------- ...

Financial Data and Key Metrics - The company achieved stable and strong profitability in Q1 2024, marking seven consecutive quarters of improved operating results across all business segments [18] - Consolidated revenue for Q1 2024 was $233 million, with adjusted EBITDA at negative $11 million, representing a year-over-year improvement of over $16 million compared to Q1 2023 [54] - SelectRx surpassed 52,000 members, with healthcare services revenue exceeding senior revenues for the first time in company history [19] - Senior distribution business grew revenue by 16% year-over-year, with MA approved policies increasing by 17% to 98,000 [29][63] - Life and Auto & Home segments combined revenues were $47 million, up nearly 7% year-over-year, with adjusted EBITDA totaling nearly $9 million [47][44] Business Line Performance - SelectRx membership grew by over 60% year-over-year, reaching 52,000 members, driven primarily by Medicare Advantage interactions [67] - Healthcare services revenue grew by 50% year-over-year, driven by the maturation of the membership base and increased full-box utilization [5] - Senior distribution business saw a 22% decline in operating expense per policy, a 30% improvement in marketing expense per policy, and a 25% increase in agent close rates year-over-year [65] - Life business benefited from the adoption of the SwiftTerm Select product, while Auto & Home remained stable despite a challenging P&C insurance market [47] Market Performance - The company is well-positioned to serve all 50 states, with a single pharmacy system that is more efficient and integrated with automated fulfillment and shipping functions [58] - The Medicare Advantage market continues to show strong demand, with over 4 million Americans turning 65 each year, providing a long-term growth opportunity [40] - The company has seen deeper coordination with carriers, improving onboarding experiences and retention behavior [22] Strategic Direction and Industry Competition - The company’s strategy focuses on tenured agents, high-quality leads, and advanced technology tools to drive efficiency and policyholder persistency [20][21] - SelectRx is seen as a key differentiator, with the platform enabling differentiated customer acquisition and engagement, positioning the company at an advantageous intersection in the healthcare ecosystem [59] - The company is exploring additional market opportunities to leverage its platform for delivering value in the healthcare ecosystem [60] Management Commentary on Operating Environment and Future Outlook - Management expressed confidence in the company’s preparation for the AEP and OEP seasons, with early results aligning with expectations [53] - The company expects to achieve attractive EBITDA margins in the low 20s for the senior distribution business in fiscal 2024 [32] - Management highlighted the importance of the healthcare services segment in offsetting seasonal expenses and driving future profitability [28] Other Important Information - The company emphasized its unique value proposition, combining Medicare Advantage distribution with tailored prescription drug delivery to drive higher patient medication adherence [25] - SelectRx’s revenue per member per month is more than 35% higher than the prior business, reflecting improved unit economics [24] - The company’s tenured agent retention remains strong, providing a key strategic advantage in the competitive Medicare Advantage market [55] Q&A Session Summary Question: Impact of regulatory changes on AEP performance - The company noted that regulatory changes, such as the 48-hour rule, had some impact but were in line with expectations, with no significant disruptions observed [34][69] - Management highlighted that the company’s alignment with carriers and focus on high-adherence solutions has been well-received, contributing to positive persistency and adherence metrics [77][71] Question: Growth trajectory and operational readiness for SelectRx - Management expressed confidence in SelectRx’s growth trajectory, expecting membership growth of 25% and healthcare services revenue growth of 50% for the year [5] - The company has scaled operations effectively, with customer satisfaction and NPS scores being strong indicators of operational readiness [70] Question: Outlook on P&C insurance market - The company acknowledged the challenging P&C insurance market but noted that carriers are adjusting underwriting practices, with the business continuing to perform well [80] Question: EBITDA cadence for fiscal 2024 - Management expects the EBITDA cadence to follow historical patterns, with healthcare services projected to achieve low single-digit EBITDA margins, improving as the business scales [74] Question: Plan design and shopping behavior - Management observed that plan features this year are similar to last season, with carriers focusing on maintaining critical consumer benefits, leading to stable shopping behavior [86][92]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR (Registrant's telephone number, including area code) (Former name, former address and former fiscal year, if changed since last report) ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Securities registered pursuant to Section ...

SelectQuote, Inc. (NYSE:SLQT) Q4 2023 Earnings Call Transcript September 13, 2023 8:30 AM ET Company Participants Matt Gunter - Investor Relations Tim Danker - Chief Executive Officer Ryan Clement - Chief Financial Officer Bob Grant - President Conference Call Participants Jonathan Yong - Credit Suisse Daniel Grosslight - Citigroup Ben Hendrix - RBC Operator Hello, and welcome to SelectQuote’s Fiscal Fourth Quarter and Full Year 2023 Earnings Call. My name is Elliot and I'll be coordinating your call today. ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 001-39295 (Commission File Number) SelectQuote, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organiz ...

SelectQuote, Inc. (NYSE:SLQT) Q3 2023 Earnings Conference Call May 11, 2023 8:30 AM ET Company Participants Matthew Gunter - Chief Communications Officer and Investor Relations Timothy Danker - Chief Executive Officer Ryan Clement - Chief Financial Officer William Grant - Chief Operating Officer Robert Clay Grant - President Conference Call Participants Jonathan Yong - Credit Suisse Daniel Grosslight - Citigroup Inc. Ben Hendrix - RBC Capital Markets Operator Hello, everyone, and welcome to SelectQuote Thir ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 001-39295 (Commission File Number) Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required t ...

SelectQuote Inc. (NYSE:SLQT) Q2 2023 Earnings Conference Call February 7, 2023 8:30 AM ET Company Participants Tim Danker - Chief Executive Officer Ryan Clement - Senior Vice President, Finance, interim Chief Financial Officer Bill Grant - Chief Operating Officer Matt Gunter - Chief Communications Officer, Investor Relations Conference Call Participants Daniel Grosslight - Citigroup Ben Hendrix - RBC Capital Markets Operator Hello and welcome to SelectQuote’s second quarter fiscal year 2023 earnings confere ...